Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 151.10K | 130.10K | 137.50K | 99.60K | 148.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.10K | 130.10K | 137.50K | 99.60K | 148.90K |
| Cost of Revenue | 39.20K | 59.20K | 41.90K | 35.90K | 45.00K |
| Gross Profit | 111.90K | 70.90K | 95.60K | 63.70K | 103.90K |
| SG&A Expenses | 106.90K | 132.00K | 146.20K | 125.90K | 130.70K |
| Depreciation & Amortization | 31.60K | 20.20K | 19.50K | 19.60K | 19.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 177.70K | 211.40K | 207.50K | 181.40K | 195.40K |
| Operating Income | -26.60K | -81.40K | -70.10K | -81.80K | -46.50K |
| Income Before Tax | -29.00K | -114.20K | -84.40K | -95.90K | -40.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -29.00K | -114.20K | -84.40K | -95.90K | -40.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.00K | -114.20K | -84.40K | -95.90K | -40.20K |
| EBIT | -26.60K | -81.40K | -70.10K | -81.80K | -46.50K |
| EBITDA | 5.00K | -72.10K | -61.50K | -73.20K | -26.80K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Average Diluted Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |